Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer
Clinical trial NCT04395612 · UNKNOWN
Trial details
- NCT number
- NCT04395612
- Sponsor
- Chongqing University Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2022-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.